Medpace
MEDP
324 hedge funds and large institutions have $4.87B invested in Medpace in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 113 increasing their positions, 129 reducing their positions, and 22 closing their positions.
74% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $8.99M
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
6% more capital invested
Capital invested by funds: $4.59B → $4.87B (+$280M)
2% more funds holding
Funds holding: 319 → 324 (+5)
1.79% less ownership
Funds ownership: 78.53% → 76.73% (-1.8%)
12% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 129
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ESCM
Echo Street Capital Management
New York
|
+$43.1M |
| 2 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$38.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.1M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$17M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$35.3M |
| 2 |
BlackRock
New York
|
-$26.6M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$22.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$20M |
MEDP Hedge Fund Activity: Q2 2021 in Review
324 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2021, worth a combined $4.87B — up 6.1% from $4.59B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new MEDP positions and 22 closed out — a net gain of 7 holders — while 113 added to existing stakes and 129 trimmed.
The largest buyer was Echo Street Capital Management, adding an estimated $43.1M. The largest seller was Wasatch Advisors, cutting an estimated $35.3M.
- 324 institutional investors held Medpace (MEDP) as of Q2 2021, up from 319 in Q1 2021.
- Funds reported $4.87B of Medpace stock for Q2 2021, up 6.1% quarter-over-quarter.
- 29 funds opened new Medpace positions in Q2 2021 and 22 closed out, a net change of +7 holders.
- The largest Medpace buyer in Q2 2021 was Echo Street Capital Management, an estimated $43.1M added.
- The largest Medpace seller in Q2 2021 was Wasatch Advisors, an estimated $35.3M sold.
Based on aggregated 13F filings for Q2 2021.